BioLife Solutions, Inc. (BLFS)

BioLife Solutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	95.39	27.9	19.44	69.86	90.4
Short-Term Investments	9.2	16.29	43.26	-	-
Cash & Short-Term Investments	104.58	44.18	62.7	69.86	90.4
Cash Growth	136.70%	-29.53%	-10.25%	-22.72%	1302.03%
Receivables	9.17	7.9	33.94	23.22	8.01
Inventory	29.01	27.16	34.9	28.35	11.6
Prepaid Expenses	6	4.67	6.88	4.66	4.65
Restricted Cash	-	-	0.03	0.01	0.05
Other Current Assets	-	36.69	-	-	-
Total Current Assets	148.76	120.6	138.45	126.09	114.71
Property, Plant & Equipment	22.86	19.48	48.27	46.61	24.52
Long-Term Investments	5.62	5.62	6.4	4.37	5.87
Goodwill	212.3	212.3	224.74	224.74	58.45
Other Intangible Assets	9.56	12	32.09	152.15	31.05
Other Long-Term Assets	0.38	42.71	0.28	0.33	0.23
Total Assets	399.49	412.71	450.23	554.29	234.83
Accounts Payable	3.57	2.27	15.37	14.95	3.67
Accrued Expenses	16.6	13.22	12.36	8.6	3.37
Current Portion of Long-Term Debt	10.94	6.29	1.81	0.86	0.61
Current Portion of Leases	1.51	1.29	3.02	2.91	1.12
Current Income Taxes Payable	-	0.26	0.98	0.03	0.11
Current Unearned Revenue	0.1	0.04	0.55	0.81	0.93
Other Current Liabilities	-	18.82	10.5	14.55	5.76
Total Current Liabilities	32.73	42.18	44.58	42.7	15.57
Long-Term Debt	5	17.56	23.79	6.35	0.66
Long-Term Leases	12.72	8.7	15.09	16.76	8.77
Long-Term Deferred Tax Liabilities	0.12	0.11	0.25	5.49	-
Other Long-Term Liabilities	-	6.5	2.33	4.94	4.59
Total Liabilities	50.58	75.05	86.04	76.24	29.58
Common Stock	0.05	0.05	0.04	0.04	0.03
Additional Paid-In Capital	683.94	652.88	611.74	585.4	302.6
Retained Earnings	-335.1	-314.92	-246.92	-107.11	-97.39
Comprehensive Income & Other	0.02	-0.35	-0.68	-0.28	-
Total Common Equity	348.91	337.66	364.19	478.05	205.25
Shareholders' Equity	348.91	337.66	364.19	478.05	205.25
Total Liabilities & Equity	399.49	412.71	450.23	554.29	234.83
Total Debt	30.17	33.83	43.71	26.88	11.15
Net Cash (Debt)	79.04	10.91	18.99	42.98	79.25
Net Cash Growth	624.79%	-42.57%	-55.82%	-45.77%	1459.73%
Net Cash Per Share	1.72	0.25	0.44	1.12	2.90
Filing Date Shares Outstanding	47	45.3	43.21	42.09	33.4
Total Common Shares Outstanding	46.91	45.17	42.83	41.82	33.04
Working Capital	116.03	78.43	93.87	83.39	99.14
Book Value Per Share	7.44	7.48	8.50	11.43	6.21
Tangible Book Value	127.05	113.36	107.36	101.16	115.75
Tangible Book Value Per Share	2.71	2.51	2.51	2.42	3.50
Machinery	13.88	13.8	30.14	24.18	14.15
Construction In Progress	5.58	5.16	6.75	4.42	2.54
Leasehold Improvements	3.53	3.5	5.25	3.84	2.39

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q